Simplify Logo

Full-Time

Software Engineer

Remote

Confirmed live in the last 24 hours

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing for heart disease

Data & Analytics
Hardware
AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$108k - $181.5kAnnually

+ Cash Bonus + Stock Options

Mid

Austin, TX, USA + 2 more

Category
Backend Engineering
Software QA & Testing
Software Engineering
Required Skills
Agile
Python
NoSQL
Data Structures & Algorithms
Docker
AWS
MongoDB
REST APIs
Linux/Unix
Requirements
  • Large scale and distributed computing systems
  • Web services and RESTful APIs
  • Horizontal scalability of services
  • Amazon Web Services (AWS), or another cloud provider
  • Containerization technologies, such as Docker or equivalent
  • RDBMS
  • NoSQL or non-relational database like DynamoDB, MongoDB or equivalent
  • Python (advanced programming)
  • Applying data structures, algorithms, and object-oriented principles to solve challenging problems
  • Linux, (advanced systems knowledge)
  • Continuous Integration platforms
  • Continuous delivery pipelines
  • Debugging distributed cloud services
  • Software development best practices, and agile methodologies
  • Unit, Functional, and Black Box testing of software Applications
  • DICOM and/or HL7 standards
  • Enterprise Imaging Software development and interoperability concepts
  • Software as a Medical Device (SaMD)
  • Bachelor’s degree in Computer Science, or equivalent experience
  • 3+ year(s) of relevant work experience in a major software company, including: 3+ year(s) of experience in software development
Responsibilities
  • Own and drive the development of multiple components within the team according to best practices in software development and the standards and guidance set forth by FDA and other regulated bodies.

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company's product offerings include the HeartFlow Analysis, which consists of various analyses like FFRCT, RoadMap, and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries including the US, UK, Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning and patient safety. The goal of HeartFlow is to improve cardiovascular care by providing advanced diagnostic tools that facilitate better treatment decisions.

Company Stage

Series F

Total Funding

$1.2B

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

6%

1 year growth

13%

2 year growth

17%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $215 million Series F funding round led by Bain Capital Life Sciences positions HeartFlow for significant growth and expansion.
  • HeartFlow's AI-enabled products, such as the RoadMap Analysis, enhance diagnostic accuracy and efficiency, potentially improving patient outcomes and physician workflows.
  • With coverage by 100% of Medicare and over 98% of commercial payers, HeartFlow's technology is widely accessible, increasing its adoption and market penetration.

What critics are saying

  • The cardiovascular care market is highly competitive, requiring continuous innovation to maintain a leading position.
  • Regulatory hurdles and the need for ongoing FDA clearances could delay product launches and market entry.

What makes HeartFlow unique

  • HeartFlow's non-invasive cardiac test offers a safer and more efficient alternative to traditional invasive procedures, setting it apart in the cardiovascular care market.
  • The company's comprehensive product portfolio, including FFRCT, RoadMap, and Plaque Analysis, provides a unique combination of anatomical and physiological visualization of coronary arteries.
  • HeartFlow's technology has received FDA clearance and is commercially available in multiple countries, ensuring a broad market reach and regulatory credibility.